Montpellier Rio Imaging to Use Definiens' Image Analysis Tech | GenomeWeb
NEW YORK (GenomeWeb News) – Montpellier Rio Imaging will use Definiens’ high-content image analysis and data management technology at its lab in the Languedoc-Roussillon region of France, Definiens said Monday.
 
MRI said it will use the technology in its automated offerings for cell-based assays and large-scale histopathology research.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.